Innovations in Clinical Neuroscience | A peer-reviewed journal providing evidence-based information

Agomelatine: A Novel Antidepressant

November 2011

by Randy A. Sansone, MD, and Lori A. Sansone, MD

Dr. R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine in Dayton, Ohio, and Director of Psychiatry Education at Kettering Medical Center in Kettering, Ohio; Dr. L. Sansone is a family medicine physician (civilian) and Medical Director, Family Health Clinic, Wright-Patterson Medical Center in WPAFB, Ohio. The views and opinions expressed in this column are those of the authors and do not reflect the official policy or position of the United States Air Force, Department of Defense, or US government.

Innov Clin Neurosci. 2011;8(11):10–14 Read the rest of this article »

Posted in The Interface | No Comments »

Generic Penetration in the Retail Antidepressant Market

June 2010


by Jeffrey Ventimiglia and Amir H. Kalali, MD
Mr. Ventimiglia is Analyst, Strategy and Solutions, Global Customer Management, Quintiles, Inc., Durham, North Carolina; Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles, Inc., and Professor of Psychiatry, University of California, San Diego, California.

Psychiatry (Edgemont) 2010;7(6):9–11
Read the rest of this article »

Posted in Trend Watch | 1 Comment »

Decreased Use of Antidepressants in Youth After US Food and Drug Administration Black Box Warning

October 2009

by Tanvir Singh, MD; Ashwin Prakash, MD; Theodore Rais, MD; and Neeta Kumari, MD, MPH

Dr. Singh is Assistant Professor, Department of Child and Adolescent Psychiatry, University of Toledo Medical Center, Toledo, Ohio; Dr. Prakash is from the Department of Child and Adolescent Psychiatry, University of Toledo Medical Center, Toledo, Ohio; Dr. Rais is Associate Professor, Department of Child and Adolescent Psychiatry, University of Toledo Medical Center, Toledo, Ohio; and Dr. Kumari is from the Department of Public Health, University Toledo Medical Center, Toledo, Ohio.

Psychiatry (Edgemont) 2009;6(10):30–34
Read the rest of this article »

Posted in Original Research | No Comments »

Warfarin and Antidepressants: Happiness without Hemorrhaging

July 2009

by Randy A. Sansone, MD, and Lori A. Sansone, MD

Dr. R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine in Dayton, Ohio, and Director of Psychiatry Education at Kettering Medical Center in Kettering, Ohio; Dr. L. Sansone is a family medicine physician (government service) and Medical Director of the Primary Care Clinic at Wright-Patterson Air Force Base. The views and opinions expressed in this column are those of the authors and do not reflect the official policy or the position of the United States Air Force, Department of Defense, or US government.

Read the rest of this article »

Posted in The Interface | No Comments »

Extended-release Trazodone in Major Depressive Disorder: A Randomized, Double-blind, Placebo-controlled Study

May 2009

by David V. Sheehan, MD, MBA; Harry A. Croft, MD; E. Roderich Gossen, PhD; Randy J. Levitt, PhD; Claire Brullé, MD; Sylvie Bouchard, MD, PhD; Anna Rozova, MSc, MD

Dr. Sheehan is Distinguished University Health Professor, Professor of Psychiatry, Director, Depression and Anxiety Disorders Research Institute, University of South Florida College of Medicine, Tampa, Florida; Dr. Croft is Medical Director, San Antonio Psychiatric Research Center, San Antonio, Texas; Drs. Gossen, Levitt, Brullé, and Rozova are from Labopharm Inc., Laval, Québec, Canada; and Dr. Bouchard is from Lakeshore General Hospital, Montréal, Québec, Canada.
Read the rest of this article »

Posted in Original Research | 1 Comment »

Tramadol: Seizures, Serotonin Syndrome, and Coadministered Antidepressants

April 2009

by Randy A. Sansone, MD, and Lori A. Sansone, MD

Dr. R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine in Dayton, Ohio, and Director of Psychiatry Education at Kettering Medical Center in Kettering, Ohio; Dr. L. Sansone is a family medicine physician (government service) and Medical Director of the Primary Care Clinic at Wright-Patterson Air Force Base. The views and opinions expressed in this column are those of the authors and do not reflect the official policy or the position of the United States Air Force, Department of Defense, or US government.
Read the rest of this article »

Posted in The Interface | No Comments »

Treatment of Schizoaffective Disorder

March 2009

by Elisa Cascade; Amir H. Kalali, MD; and Peter Buckley, MD

Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles Inc., San Diego, California, and Professor of Psychiatry, University of California, San Diego; and Dr. Buckley is Professor and Chairman, Department of Psychiatry, Medical College of Georgia, Augusta, Georgia.

Read the rest of this article »

Posted in Trend Watch | No Comments »

Real-World Data on SSRI Antidepressant Side Effects

February 2009

by Elisa Cascade; Amir H. Kalali, MD; and Sidney H. Kennedy, MD, FRCPC

Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles Inc., San Diego, California, and Professor of Psychiatry, University of California, San Diego; Dr. Kennedy is Psychiatrist-in-Chief, University Health Network, Toronto, Ontario, Canada.

Read the rest of this article »

Posted in Trend Watch | No Comments »

Antidepressant Prescribing by Specialty and Treatment of Premenstrual Dysphoric Disorder

December 2008

by Elisa Cascade; Amir H. Kalali, MD; and Uriel Halbreich, MD

Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles Inc., San Diego, California, and Professor of Psychiatry, University of California, San Diego; and Dr. Halbreich is Director, Biobehavior Research, Professor of Psychiatry and OB/GYN, SUNY, WPA Section on Interdisciplinary Collaboration, Buffalo, New York.
Read the rest of this article »

Posted in Trend Watch | No Comments »

Use of Benzodiazepines in the Treatment of Anxiety

September 2008

by Elisa Cascade and Amir H. Kalali, MD

Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; and Dr. Kalali is Vice President, Global Therapeutic Group Leader CNS, Quintiles Inc., San Diego, California, and Professor of Psychiatry, University of California, San Diego.

Read the rest of this article »

Posted in Trend Watch | No Comments »